2024-04-012025-03-312025-03-31false08436959SAMEE BRITISH HAIR CLINIC LTD2025-12-19falseiso4217:GBPxbrli:pure084369592024-03-31084369592025-03-31084369592024-04-012025-03-31084369592023-03-31084369592024-03-31084369592023-04-012024-03-3108436959bus:SmallEntities2024-04-012025-03-3108436959bus:AuditExempt-NoAccountantsReport2024-04-012025-03-3108436959bus:AbridgedAccounts2024-04-012025-03-3108436959bus:PrivateLimitedCompanyLtd2024-04-012025-03-3108436959core:WithinOneYear2025-03-3108436959core:AfterOneYear2025-03-3108436959core:WithinOneYear2024-03-3108436959core:AfterOneYear2024-03-3108436959core:ShareCapital2025-03-3108436959core:SharePremium2025-03-3108436959core:RevaluationReserve2025-03-3108436959core:OtherReservesSubtotal2025-03-3108436959core:RetainedEarningsAccumulatedLosses2025-03-3108436959core:ShareCapital2024-03-3108436959core:SharePremium2024-03-3108436959core:RevaluationReserve2024-03-3108436959core:OtherReservesSubtotal2024-03-3108436959core:RetainedEarningsAccumulatedLosses2024-03-3108436959core:LandBuildings2025-03-3108436959core:PlantMachinery2025-03-3108436959core:Vehicles2025-03-3108436959core:FurnitureFittings2025-03-3108436959core:OfficeEquipment2025-03-3108436959core:NetGoodwill2025-03-3108436959core:IntangibleAssetsOtherThanGoodwill2025-03-3108436959core:ListedExchangeTraded2025-03-3108436959core:UnlistedNon-exchangeTraded2025-03-3108436959core:LandBuildings2024-03-3108436959core:PlantMachinery2024-03-3108436959core:Vehicles2024-03-3108436959core:FurnitureFittings2024-03-3108436959core:OfficeEquipment2024-03-3108436959core:NetGoodwill2024-03-3108436959core:IntangibleAssetsOtherThanGoodwill2024-03-3108436959core:ListedExchangeTraded2024-03-3108436959core:UnlistedNon-exchangeTraded2024-03-3108436959core:LandBuildings2024-04-012025-03-3108436959core:PlantMachinery2024-04-012025-03-3108436959core:Vehicles2024-04-012025-03-3108436959core:FurnitureFittings2024-04-012025-03-3108436959core:OfficeEquipment2024-04-012025-03-3108436959core:NetGoodwill2024-04-012025-03-3108436959core:IntangibleAssetsOtherThanGoodwill2024-04-012025-03-3108436959core:ListedExchangeTraded2024-04-012025-03-3108436959core:UnlistedNon-exchangeTraded2024-04-012025-03-3108436959core:MoreThanFiveYears2024-04-012025-03-3108436959core:Non-currentFinancialInstruments2025-03-3108436959core:Non-currentFinancialInstruments2024-03-3108436959dpl:CostSales2024-04-012025-03-3108436959dpl:DistributionCosts2024-04-012025-03-3108436959core:LandBuildings2024-04-012025-03-3108436959core:PlantMachinery2024-04-012025-03-3108436959core:Vehicles2024-04-012025-03-3108436959core:FurnitureFittings2024-04-012025-03-3108436959core:OfficeEquipment2024-04-012025-03-3108436959dpl:AdministrativeExpenses2024-04-012025-03-3108436959core:NetGoodwill2024-04-012025-03-3108436959core:IntangibleAssetsOtherThanGoodwill2024-04-012025-03-3108436959dpl:GroupUndertakings2024-04-012025-03-3108436959dpl:ParticipatingInterests2024-04-012025-03-3108436959dpl:GroupUndertakingscore:ListedExchangeTraded2024-04-012025-03-3108436959core:ListedExchangeTraded2024-04-012025-03-3108436959dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-04-012025-03-3108436959core:UnlistedNon-exchangeTraded2024-04-012025-03-3108436959dpl:CostSales2023-04-012024-03-3108436959dpl:DistributionCosts2023-04-012024-03-3108436959core:LandBuildings2023-04-012024-03-3108436959core:PlantMachinery2023-04-012024-03-3108436959core:Vehicles2023-04-012024-03-3108436959core:FurnitureFittings2023-04-012024-03-3108436959core:OfficeEquipment2023-04-012024-03-3108436959dpl:AdministrativeExpenses2023-04-012024-03-3108436959core:NetGoodwill2023-04-012024-03-3108436959core:IntangibleAssetsOtherThanGoodwill2023-04-012024-03-3108436959dpl:GroupUndertakings2023-04-012024-03-3108436959dpl:ParticipatingInterests2023-04-012024-03-3108436959dpl:GroupUndertakingscore:ListedExchangeTraded2023-04-012024-03-3108436959core:ListedExchangeTraded2023-04-012024-03-3108436959dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-04-012024-03-3108436959core:UnlistedNon-exchangeTraded2023-04-012024-03-3108436959core:NetGoodwill2025-03-3108436959core:IntangibleAssetsOtherThanGoodwill2025-03-3108436959core:LandBuildings2025-03-3108436959core:PlantMachinery2025-03-3108436959core:Vehicles2025-03-3108436959core:FurnitureFittings2025-03-3108436959core:OfficeEquipment2025-03-3108436959core:AfterOneYear2025-03-3108436959core:WithinOneYear2025-03-3108436959core:ListedExchangeTraded2025-03-3108436959core:UnlistedNon-exchangeTraded2025-03-3108436959core:ShareCapital2025-03-3108436959core:SharePremium2025-03-3108436959core:RevaluationReserve2025-03-3108436959core:OtherReservesSubtotal2025-03-3108436959core:RetainedEarningsAccumulatedLosses2025-03-3108436959core:NetGoodwill2024-03-3108436959core:IntangibleAssetsOtherThanGoodwill2024-03-3108436959core:LandBuildings2024-03-3108436959core:PlantMachinery2024-03-3108436959core:Vehicles2024-03-3108436959core:FurnitureFittings2024-03-3108436959core:OfficeEquipment2024-03-3108436959core:AfterOneYear2024-03-3108436959core:WithinOneYear2024-03-3108436959core:ListedExchangeTraded2024-03-3108436959core:UnlistedNon-exchangeTraded2024-03-3108436959core:ShareCapital2024-03-3108436959core:SharePremium2024-03-3108436959core:RevaluationReserve2024-03-3108436959core:OtherReservesSubtotal2024-03-3108436959core:RetainedEarningsAccumulatedLosses2024-03-3108436959core:NetGoodwill2023-03-3108436959core:IntangibleAssetsOtherThanGoodwill2023-03-3108436959core:LandBuildings2023-03-3108436959core:PlantMachinery2023-03-3108436959core:Vehicles2023-03-3108436959core:FurnitureFittings2023-03-3108436959core:OfficeEquipment2023-03-3108436959core:AfterOneYear2023-03-3108436959core:WithinOneYear2023-03-3108436959core:ListedExchangeTraded2023-03-3108436959core:UnlistedNon-exchangeTraded2023-03-3108436959core:ShareCapital2023-03-3108436959core:SharePremium2023-03-3108436959core:RevaluationReserve2023-03-3108436959core:OtherReservesSubtotal2023-03-3108436959core:RetainedEarningsAccumulatedLosses2023-03-3108436959core:AfterOneYear2024-04-012025-03-3108436959core:WithinOneYear2024-04-012025-03-3108436959core:Non-currentFinancialInstrumentscore:CostValuation2024-04-012025-03-3108436959core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-04-012025-03-3108436959core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-04-012025-03-3108436959core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-04-012025-03-3108436959core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-04-012025-03-3108436959core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-04-012025-03-3108436959core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3108436959core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3108436959core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3108436959core:Non-currentFinancialInstrumentscore:CostValuation2025-03-3108436959core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-03-3108436959core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-03-3108436959core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-03-3108436959core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-03-3108436959core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-03-3108436959core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-03-3108436959core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-03-3108436959core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-03-3108436959core:Non-currentFinancialInstrumentscore:CostValuation2024-03-3108436959core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-03-3108436959core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-03-3108436959core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-03-3108436959core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-03-3108436959core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-03-3108436959core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-03-3108436959core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-03-3108436959core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-03-3108436959bus:Director12024-04-012025-03-31

SAMEE BRITISH HAIR CLINIC LTD

Registered Number
08436959
(England and Wales)

Unaudited Financial Statements for the Year ended
31 March 2025

SAMEE BRITISH HAIR CLINIC LTD
Company Information
for the year from 1 April 2024 to 31 March 2025

Director

DR ZABEEH ULLAH

Company Secretary

SADIA SAMEE

Registered Address

Hamilton House
4a The Avenue
London
E4 9LD

Registered Number

08436959 (England and Wales)
SAMEE BRITISH HAIR CLINIC LTD
Balance Sheet as at
31 March 2025

Notes

2025

2024

£

£

£

£

Fixed assets
Tangible assets3262,731271,614
262,731271,614
Current assets
Stocks54,3594,734
Debtors66,565653
Current asset investments125,450-
Cash at bank and on hand38,519161,474
174,893166,861
Creditors amounts falling due within one year7(79,967)(132,462)
Net current assets (liabilities)94,92634,399
Total assets less current liabilities357,657306,013
Net assets357,657306,013
Capital and reserves
Called up share capital100100
Profit and loss account357,557305,913
Shareholders' funds357,657306,013
The financial statements were approved and authorised for issue by the Director on 19 December 2025, and are signed on its behalf by:
DR ZABEEH ULLAH
Director
Registered Company No. 08436959
SAMEE BRITISH HAIR CLINIC LTD
Notes to the Financial Statements
for the year ended 31 March 2025

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in compliance with FRS 102 Section 1A as it applies to the financial statements for the period and there were no material departures from the reporting standard.
Turnover policy
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services.
Revenue from sale of goods
Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Employee benefits
Contributions to defined contribution plans are expensed in the period to which they relate.
Defined contribution pension plan
The company operates a defined contribution pension plan for the benefit of its employees. Contributions are recognised as expenses as they become payable. Differences between contributions payable in the year and those actually paid are recognised as either prepayments or accruals in the balance sheet. The assets of the defined contribution pension scheme are held separately from those of the company in an independently administered fund.
Current taxation
Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Tangible fixed assets and depreciation
Tangible fixed assets are stated at cost or valuation less depreciation. Depreciation is provided on all tangible fixed assets as follows:

Reducing balance (%)Straight line (years)
Plant and machinery20-
Fixtures and fittings-3
Vehicles20-
Investments
Investments in subsidiaries, associates and joint ventures are measured at cost less any accumulated impairment losses. Listed investments are measured at fair value where the difference between cost and fair value is material. Unlisted investments are measured at fair value unless the value cannot be measured reliably, in which case they are measured at cost less any accumulated impairment losses. Changes in fair value are included in the profit and loss account.
Stocks and work in progress
Stocks are valued at the lower of cost and estimated selling price (less any associated costs to enable such sales to complete).
Cash and cash equivalents
Cash and cash equivalents comprise cash at bank and on hand, demand deposits with banks and other short-term highly liquid investments with original maturities of three months or less. Bank overdrafts are disclosed separately. For the purpose of the cash flow statement, bank overdrafts form an integral part of the company's cash management and are included as a component of cash and cash equivalents.
2.Average number of employees

20252024
Average number of employees during the year107
3.Tangible fixed assets

Total

£
Cost or valuation
At 01 April 24566,654
Additions24,702
Disposals(62,792)
At 31 March 25528,564
Depreciation and impairment
At 01 April 24295,040
Charge for year18,481
On disposals(47,688)
At 31 March 25265,833
Net book value
At 31 March 25262,731
At 31 March 24271,614
4.Fixed asset investments

Total

£
Cost or valuation
Additions125,450
At 31 March 25125,450
Impairment
Acquisitions125,450
At 31 March 25125,450
Net book value
At 31 March 25-
At 31 March 24-
5.Stocks
Stocks are measured at the lower of cost and estimated selling price less costs to complete and sell. Cost is determined using the first in first out method. The carrying amount of stock sold is recognised as an expense in the period in which the related revenue is recognised.

2025

2024

££
Other stocks4,3594,734
Total4,3594,734
6.Debtors: amounts due within one year

2025

2024

££
Prepayments and accrued income6,565653
Total6,565653
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.
7.Creditors: amounts due within one year

2025

2024

££
Trade creditors / trade payables12,75538,457
Taxation and social security50,55773,098
Other creditors57
Accrued liabilities and deferred income16,65020,900
Total79,967132,462
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.